| Academic Unit: |
Molecular Biology and Genetics |
| Mode of Delivery: |
Face to face |
| Prerequisites: |
None |
| Language of Instruction: |
English |
| Level of Course Unit: |
Undergraduate |
| Course Coordinator: |
- - |
| Course Objectives: |
To provide an overview of pharmacophore and pharmacophore modeling applications in drug discovery and ADME-tox. Two approaches will be studied such as structure based and ligand-based pharmacophore modeling. Also, some docking techniques and virtual screening will be introduced. Finally, to present BIOVIA Discovery Studio (DS) computer program for pharmacophore modeling and drug discovery. |
| Course Contents: |
Overview of Ligand- Protein Interactions, Pharmacophore Modeling, Drug Discovery, Current Challenges in Pharmacophore Modeling, Structure Based Pharmacophore Modeling, Ligand Based Pharmacophore Modeling Software’s: Biovia discovery Studio, AutoDock, Virtual Screening |
| Learning Outcomes of the Course Unit (LO): |
- 1- To have a knowledge about of what is pharmacophore.
- 2- To understand the concept of pharmacophore modeling.
- 3- Able to describe and discuss current challenges in drug discovery.
- 4- Able to describe different techniques used in pharmacophore modeling
- 5- Able to use BIOVIA DS
- 6- Able to set up a virtual screening experiment
- 7- To understand the concept behind pharmacophore screening, QSAR, ADMET
|
| Planned Learning Activities and Teaching Methods: |
One midterm exam, a final exam, project and Homework (Exercises) |
| Week | Subjects | Related Preperation |
| 1 |
Overview of Pharmacophore Modeling |
Reading the related chapter from textbook |
| 2 |
What is Computer-Aided Drug Design |
Reading the related chapter from textbook |
| 3 |
Overview of Ligand-Protein Interactions |
Reading the related chapter from textbook |
| 4 |
Pharmacophore modeling in virtual screening |
Reading the related chapter from textbook |
| 5 |
Pharmacophore methods in docking simulations |
Reading the related chapter from textbook |
| 6 |
Applications of pharmacophores in ADME-tox |
Study of the chapters covered in weeks 1 through 5 |
| 7 |
Pharmacophore-guided drug target identification |
Reading the related chapter from textbook |
| 8 |
Introduction to software tool AutoDock |
Installing AutoDock related programs on your personal computer |
| 9 |
Introduction to BIVIA DS |
Practical |
| 10 |
Virtual Screening |
Practical |
| 11 |
Midterm Project |
Practical |
| 12 |
Future perspectives on pharmacophore modeling |
Reading the related chapter from textbook |
| 13 |
Fragment-based drug design |
Reading the related chapter from textbook |
| 14 |
Final Project |
Study of the chapters covered in weeks 9 through 12 |
At Kadir Has University, a Semester is 14 weeks; The weeks 15 and 16 are reserved for final exams.
Pharmacophore modeling: advances, limitations, and current utility in drug discovery; Xiaoyu Qing, Xiao Yin Lee, Joren De Raeymaeker, Jeremy RH Tame, Kam YJ Zhang, Marc De Maeyer, Arnout RD Voet
Pharmacophore Approaches In Drug Discovery; Thierry Langer
ThreeDimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors; Kalapatapu V.V.M. Sairam, Roop K. Khar, Rama Mukherjee and Swatantra K. Jain
Synthesis, Structure–Activity Relationship, and Pharmacophore Modeling Studies of Pyrazole-3-
Carbohydrazone Derivatives as Dipeptidyl Peptidase IV Inhibitors; Deyan Wu, Fangfang Jin, Weiqiang Lu 1, Jin Zhu, Cui Li, Wei Wang, Yun Tang, Hualiang Jiang, Jin Huang, Guixia Liu and Jian Li |
THE RELATIONSHIP BETWEEN COURSE LEARNING OUTCOMES (LO) AND PROGRAM QUALIFICATIONS (PQ)
| # |
PQ1 |
PQ2 |
PQ3 |
PQ4 |
PQ5 |
PQ6 |
PQ7 |
PQ8 |
PQ9 |
PQ10 |
PQ11 |
PQ12 |
PQ13 |
| LO1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| LO2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| LO3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| LO4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| LO5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| LO6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| LO7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution: 1 Low, 2 Average, 3 High